862723-42-0 Usage
General Description
Indazole-5-boronic acid pinacol ester is a chemical compound that belongs to the class of boronic acid esters. It is a derivative of indazole, a heterocyclic aromatic organic compound. INDAZOLE-5-BORONIC ACID PINACOL ESTER has been studied for its potential applications in medicinal chemistry, particularly as a building block for the synthesis of pharmaceutical compounds. It has also been investigated for its potential use in various catalytic processes. Indazole-5-boronic acid pinacol ester is a valuable tool for chemists and researchers working in the fields of drug discovery, organic synthesis, and catalysis. Its unique structure and reactivity make it a promising candidate for the development of new chemical and pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 862723-42-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,7,2 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 862723-42:
(8*8)+(7*6)+(6*2)+(5*7)+(4*2)+(3*3)+(2*4)+(1*2)=180
180 % 10 = 0
So 862723-42-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H17BN2O2/c1-12(2)13(3,4)18-14(17-12)10-5-6-11-9(7-10)8-15-16-11/h5-8H,1-4H3,(H,15,16)
862723-42-0Relevant articles and documents
IMIDAZO[1,2-A]PYRAZINE MODULATORS OF THE ADENOSINE A2A RECEPTOR
-
Page/Page column 78, (2019/01/17)
The present invention relates to the compound of formula (I) and salts, stereoisomers, tautomers, isotopologues,or N-oxides thereof. The present invention is further concerned with the use of such a compound or salt, stereoisomer, tautomer, isotopologues,or N-oxide thereof as medicament and a pharmaceutical composition comprising said compound.
HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES
-
Paragraph 000170; 000184; 000196, (2016/05/02)
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions in need of inhibition of heparan sulfate biosynthesis.
ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
-
Paragraph 0114; 0115; 0116; 0117; 0118, (2016/10/31)
The present invention refers to novel compounds and is provided to improve quality of an organic electroluminescent including, the present invention according to compounds are organic layer for organic electroluminescence device, preferably light-emitting